Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26,787Revenue (TTM) $M3,084Net Margin (%)12.8Altman Z-Score4.3
Enterprise Value $M28,782EPS (TTM) $1.8Operating Margin %21.6Piotroski F-Score5
P/E(ttm)68.2Beneish M-Score-2.6Pre-tax Margin (%)18.7Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales8.85-y EBITDA Growth Rate %26.5Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow35.9y-y EBITDA Growth Rate %42.7ROA % (ttm)3.0Higher Current Ratio y-yN
Dividend Yield %--PEG2.6ROE % (ttm)4.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M225ROIC % (ttm)4.3Gross Margin Increase y-yY

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ALXN is held by these investors:



ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Neill JulieEVP. Global Operations 2017-03-02Sell651$133.8-10.87view
Moriarty John BEVP & General Counsel 2017-03-01Sell1,804$131.66-9.42view
MACKAY MARTINEVP & Global Head of R&D 2017-03-01Sell1,855$131.63-9.4view
Carmichael ClareEVP, Chief HR Officer 2017-03-01Sell2,179$131.66-9.42view
Wagner Heidi LSVP, Global Government Affairs 2017-03-01Sell994$131.65-9.41view
BELL LEONARDDirector 2017-03-01Sell3,978$131.96-9.62view
O'Neill JulieEVP. Global Operations 2017-02-28Sell1,574$131.41-9.25view
Miller EdwardSVP, Chief Compliance Officer 2017-02-28Sell590$131.48-9.29view
Thiel CarstenEVP, Chief Commercial Officer 2017-02-28Sell125$74.5260.04view
Thiel CarstenEVP, Chief Commercial Officer 2017-02-28Sell3,783$131.01-8.97view

Press Releases about ALXN :

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Spiros Segalas on Alexion Pharmaceuticals Aug 18 2016 
Spiros 'Sig' Segalas' Capital Appreciation Fund 2nd Quarter Commentary Nov 07 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 06 2016 
Baron Funds Comments on Alexion Pharmaceuticals Feb 08 2016 
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals Jan 03 2016 
Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences Dec 13 2015 
Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals Dec 10 2015 

More From Other Websites
Alexion (ALXN) Files for Soliris' Label Expansion in Japan Mar 23 2017
Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for... Mar 22 2017
Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for... Mar 22 2017
Alexion (ALXN) Licenses Artubus Technology for Rare Diseases Mar 17 2017
Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product... Mar 16 2017
Pharmaceutical company to lay off more than 200 employees Mar 15 2017
Pharmaceutical company to lay off more than 200 employees Mar 15 2017
Alexion Trims Workforce, Scraps R&D Programs Mar 14 2017
Alexion Pharmaceuticals Cuts 7% of Workforce Mar 14 2017
England Says No to Drugs That Cost More Than Your Car (or Home) Mar 14 2017
Alexion to cut 7 pct of workforce Mar 13 2017
Alexion's sBLA for Soliris Receives FDA Acknowledgement Mar 10 2017
FDA Accepts sBLA Filing of Soliris® (Eculizumab) as a Potential Treatment for Patients with... Mar 08 2017
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 02 2017
Leonard Bell, M.D., Alexion’s Founder, Announces Plans to Retire as Chairman and Board Member Mar 02 2017
Coverage initiated on Alexion Pharma by Instinet Mar 02 2017
Alexion Expects This to Be Big Medicine in 2017 Mar 01 2017
Will Alexion’s Research Make Gains in the Inhibitor Space? Feb 28 2017
What Alexion Expects from Its Metabolic Disease Drugs in 2017 Feb 28 2017
Understanding Alexion’s Profit Margin Trend in 2017 Feb 28 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)